Literature DB >> 31312402

Treatment of Cancers by Inhibition of Isoprenylcysteine Carboxyl Methyltransferase.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2019        PMID： 31312402      PMCID： PMC6627714          DOI： 10.1021/acsmedchemlett.9b00269

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  To finish things well: cysteine methylation ensures selective GTPase membrane localization and signalling.

Authors:  José Cansado
Journal:  Curr Genet       Date:  2017-09-19       Impact factor: 3.886

Review 2.  Modulation of k-Ras signaling by natural products.

Authors:  S B Bharate; B Singh; R A Vishwakarma
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer.

Authors:  Neil Vasan; Julie L Boyer; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

Review 4.  Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.

Authors:  Woo Seok Yang; Seung-Gu Yeo; Sungjae Yang; Kyung-Hee Kim; Byong Chul Yoo; Jae Youl Cho
Journal:  Amino Acids       Date:  2017-06-19       Impact factor: 3.520
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.